Cargando…
Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancy.
This study was undertaken to determine the prevalence of anti-cardiolipin antibodies (ACLAs) in patients with malignancy and to investigate a possible association of ACLAs with thromboembolic events in such patients. The study included 216 patients with solid and non-solid malignancies and an age-ma...
Autores principales: | Zuckerman, E., Toubi, E., Golan, T. D., Rosenvald-Zuckerman, T., Sabo, E., Shmuel, Z., Yeshurun, D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034001/ https://www.ncbi.nlm.nih.gov/pubmed/7640230 |
Ejemplares similares
-
Lactobacillus Endocarditis-Associated Glomerulonephritis Complicated by anti-Coagulant Nephropathy and Renal Amyloidosis
por: Moosavi, Mitchell, et al.
Publicado: (2019) -
SARS-CoV-2 and Anti-Cardiolipin Antibodies
por: Jizzini, Mazen, et al.
Publicado: (2020) -
Cardiolipin, Mitochondria, and Neurological Disease
por: Falabella, Micol, et al.
Publicado: (2021) -
Post-viral idiopathic purpura fulminans is associated with inherited thrombophilia and anti-cardiolipin antibodies
por: Theron, A., et al.
Publicado: (2023) -
Impact of Antioxidants on Cardiolipin Oxidation in Liposomes: Why Mitochondrial Cardiolipin Serves as an Apoptotic Signal?
por: Lokhmatikov, Alexey V., et al.
Publicado: (2016)